0001493152-24-003445.txt : 20240123
0001493152-24-003445.hdr.sgml : 20240123
20240123161547
ACCESSION NUMBER: 0001493152-24-003445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sassi Nir
CENTRAL INDEX KEY: 0001760673
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40652
FILM NUMBER: 24552836
MAIL ADDRESS:
STREET 1: 3 ELUL STREET, APT. 6
CITY: MODIIN
STATE: L3
ZIP: 7176397
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001857044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863158720
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (646) 427-2727
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Intec Parent Inc.
DATE OF NAME CHANGE: 20210414
4
1
ownership.xml
X0508
4
2024-01-22
0
0001857044
Indaptus Therapeutics, Inc.
INDP
0001760673
Sassi Nir
C/O INDAPTUS THERAPEUTICS, INC.
3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK
NY
10019
0
1
0
0
Chief Financial Officer
0
Stock Option (Right to Buy)
1.74
2024-01-22
4
A
0
40000
0
A
2034-01-22
Common Stock
40000
40000
D
The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027.
/s/ Nir Sassi
2024-01-23